Stock · GNPX · Drug & medical companies
Members of Congress trading Genprex, Inc. (GNPX)
1 member of Congress reported 4 trades in Genprex, Inc. (GNPX) since January 2025: 4 purchases and 0 sales, worth $18K to $95K in total. Rep. Tim Moore traded it most, 4 times. The latest reported trade was on Feb 5, 2026.
- Members who traded it
- 1
- Trades since 2025
- 4
- Purchases
- 4
- Sales
- 0
- Reported value
- $18K–$95K
- Democrats / Republicans
- 0 / 1
Who in Congress trades it
- Rep. Tim Moore R-NC-144 trades
Latest trades
- Rep. Tim Moore boughtFeb 5, 2026 · $1,001–$15K
- Rep. Tim Moore boughtDec 18, 2025 · $1,001–$15K
- Rep. Tim Moore boughtNov 7, 2025 · $1,001–$15K
- Rep. Tim Moore boughtOct 29, 2025 · $15K–$50K
About these numbers
Members of Congress must report stock trades by themselves, their spouses and dependent children within 45 days, in dollar ranges rather than exact amounts. Trading stock is legal. This page lists trades reported on House and Senate periodic transaction reports since January 1, 2025, as of Oct 17, 2026.
Related
From House Clerk and Senate disclosure reports. Each member’s profile links to the original filings.
Cite or embed this page
Capitol Receipts, “Genprex (GNPX) Stock Trades by Members of Congress,” https://www.capitolreceipts.com/stock/GNPX/genprex-inc (accessed 2026-10-17).